PNPO anticorps
Aperçu rapide pour PNPO anticorps (ABIN2729268)
Antigène
Voir toutes PNPO AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Attributs du produit
- Homo sapiens pyridoxamine 5'-phosphate oxidase (PNPO)
-
Purification
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogène
- Full length human recombinant protein of human PNPO(NP_060599) produced in HEK293T cell.
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- WB 1:4000, IHC 1:150, FLOW 1:100,
-
Commentaires
-
The concentration of the product may vary between diferrent lots.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
-
- PNPO (Pyridoxamine 5'-Phosphate Oxidase (PNPO))
-
Autre désignation
- PNPO
-
Sujet
- The enzyme encoded by this gene catalyzes the terminal, rate-limiting step in the synthesis of pyridoxal 5'-phosphate, also known as vitamin B6. Vitamin B6 is a required co-factor for enzymes involved in both homocysteine metabolism and synthesis of neurotransmitters such as catecholamine. Mutations in this gene result in pyridoxamine 5'-phosphate oxidase (PNPO) deficiency, a form of neonatal epileptic encephalopathy. COMPLETENESS: complete on the 3' end.
-
Poids moléculaire
- 29.8 kDa
-
ID gène
- 55163
-
NCBI Accession
- NM_018129
-
HGNC
- 55163
Antigène
-